期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
长期服用肾上腺糖皮质激素对儿童青少年生长激素分泌的影响及重组人生长激素治疗的疗效和安全性 被引量:7
1
作者 李康 张殿喜 +6 位作者 吴勤勇 朱惠娟 龚凤英 潘慧 金自孟 邓洁英 史轶蘩 《中国医学科学院学报》 CAS CSCD 北大核心 2011年第1期1-4,共4页
目的初步探讨长期服用肾上腺糖皮质激素对儿童青少年体内人生长激素(hGH)分泌的影响并观察重组人生长激素(rhGH)治疗的疗效和安全性。方法北京协和医院1999年9月至2009年11月间诊治的12例患儿纳入本研究,其平均年龄为(10.4±1.... 目的初步探讨长期服用肾上腺糖皮质激素对儿童青少年体内人生长激素(hGH)分泌的影响并观察重组人生长激素(rhGH)治疗的疗效和安全性。方法北京协和医院1999年9月至2009年11月间诊治的12例患儿纳入本研究,其平均年龄为(10.4±1.2)岁,均使用0.5~2.0 mg/(kg.d)的泼尼松治疗6~18个月。定期评价患儿的生长发育情况,对每例患儿行2种hGH兴奋试验并对结果进行分析。其中7例患儿在原发病病情稳定后停用泼尼松,停药半年后应用0.1 U/(kg.d)的rhGH治疗6~12个月,对其疗效和安全性进行分析。结果 12例患儿在泼尼松治疗期间生长速度明显减慢,平均为(1.2±0.3)cm/年,显著低于泼尼松治疗前的(3.7±1.2)cm/年(P〈0.05)。其中10例患者行2项hGH兴奋试验hGH峰值均小于10 ng/m l。泼尼松疗程〉12个月的患儿hGH分泌异常发生率明显高于疗程为6~12个月的患儿(P〈0.05)。泼尼松剂量为0.5~1.0 mg/(kg.d)与剂量为1.0~2.0 mg/(kg.d)的患儿hGH分泌异常的发生率差异无统计学意义(P〉0.05)。7例应用rhGH治疗的患儿治疗半年后其生长速度由(2.2±0.1)cm/年增加到(7.8±0.5)cm/年(P〈0.05),治疗1年后的生长速度为(6.9±0.4)cm/年。结论长期使用泼尼松治疗能抑制患儿的hGH分泌,从而影响患儿的生长发育。对于病情稳定后停用泼尼松治疗的患儿,应用rhGH治疗可以安全有效地增加患儿的线性生长速度,改善其生长发育状况。 展开更多
关键词 肾上腺皮糖质激素 儿童 青少年 人生长激素 重组人生长激素 矮小
在线阅读 下载PDF
Effect of Calpain inhibitor I on glucocorticoid receptor-dependent degradation and its transactivation ability 被引量:1
2
作者 程晓刚 粟永萍 +1 位作者 罗成基 刘晓宏 《Journal of Medical Colleges of PLA(China)》 CAS 2004年第4期197-200,共4页
Objective: To investigate the effect of Calpain inhibitor I on glucocorticoid receptor-dependent proteasomal degradation and its transcriptional activity. Methods: After Raw-264.7 cells were treated with Calpain inhib... Objective: To investigate the effect of Calpain inhibitor I on glucocorticoid receptor-dependent proteasomal degradation and its transcriptional activity. Methods: After Raw-264.7 cells were treated with Calpain inhibitor I, dexamethasone, or both for about 12 h, the change of glucocorticoid receptor was detected by western blot analysis. COS-7 cells were transfected with PRsh-GRα expression vector and glucocorticoid-responsive receptor pMAMneo-CAT, then the effect of Calpain inhibitor I on glucocorticoid receptor transcriptional activation ability was determined by CAT activity. Results: The glucocorticoid receptor levels decreased after RAW-264.7 cells were treated with dexamethasone for 12 hours, which effect can be inhibited by Calpain inhibitor I to some extent. CAT activity assay showed that Calpain inhibitor I enhance glucocorticoid receptor transcriptional activity. Conclusion: Calpain inhibitor I can inhibit the down-regulation of dexamethasone on glucocorticoid receptor, and enhances glucocorticoid receptor transactivation ability. 展开更多
关键词 Calpain inhibitor I glucocorticoid receptor TRANSACTIVATION
在线阅读 下载PDF
Arctic spring: the arrival biology of migrant birds
3
作者 John C.WINGFIELD Noah OWEN-ASHLEY +6 位作者 Z.Morgan BENOWITZ-FRED-ERICKS Sharon E.LYNN Thomas P.HAHN Haruka WADA Creagh BRE-UNER Simone L.MEDDLE L.Michael ROMERO 《动物学报》 SCIE CAS CSCD 北大核心 2004年第6期948-960,共13页
On arrival in the Arctic, migrant birds must adjust their physiology and behavior to unpredictable snow cover, weather, food sources and predator pressure. In other words they must be resistant to environmental pertur... On arrival in the Arctic, migrant birds must adjust their physiology and behavior to unpredictable snow cover, weather, food sources and predator pressure. In other words they must be resistant to environmental perturbations (stress) so that they can migrate to their tundra nesting areas and settle on territories as soon as possible. They can then begin breeding as soon as when environmental conditions become favorable. They do this partly by using micro-habitats such as areas where snow depth is low, and patches of tundra that melt out rapidly (especially near willows Salix sp). Ground temperatures increase dramatically within hours after exposure to sun; and invertebrate activity begins simultaneously. Wind speeds are attenuated almost completely within 10 cm of the ground in willows and tussock tundra. The combination of these conditions provides an ideal refuge, especially for passerine migrants in early spring. However, if conditions worsen, the birds can leave. There are adjustments of the adrenocortical responses to stress because arctic conditions in spring are potentially severe, at least compared with wintering grounds to the south. Secretion of corticosterone in response to acute stress is enhanced at arrival in males, accompanied by a decrease in sensitivity to negative feedback and a change in responsiveness of the adrenal cortex cells to adrenocorticotropin. There is also an increase in levels of corticosterone-binding globulin (CBG) so that the actions of corticosterone are buffered according to the severity of environmental conditions. Regulation at the level of genomic receptors, particularly the low affinity glucocorticosteroid-like receptor for corticosterone in brain and liver, may be important; and non-genomic actions of corticosterone may play a major role too. In other words, the hormone-behavior system associated with arrival biology is highly flexible. 展开更多
关键词 ARCTIC Migration Stress ADRENAL CORTICOSTERONE RECEPTOR
在线阅读 下载PDF
Effects of high dose glucocorticoid on expression and mRNA transcription of corticotropin releasing hormone in hypothalamus paraventricular nucleus of rats
4
作者 张岫竹 熊健琼 +6 位作者 刘媛 曾琳 龙在云 张良 周继红 朱佩芳 王正国 《Journal of Medical Colleges of PLA(China)》 CAS 2006年第1期30-33,共4页
Objective: To explore the effect of high dose of glucocorticoid (GC) on the synthesis of corticotropin releasing hormone (CRH) and transcription of its mRNA in hypothalamus paraventricular nuclei (PVN) in order... Objective: To explore the effect of high dose of glucocorticoid (GC) on the synthesis of corticotropin releasing hormone (CRH) and transcription of its mRNA in hypothalamus paraventricular nuclei (PVN) in order to investigate its difference with that of traditional GC effects and to add a new possible explanation to the mechanism of clinical applications of high dose of GC. Methods: A total of 60 rats were divided into 5 groups: blank control, 10^-6 mol/L dexamethasone (DEX) group, 10^-9 mol/L DEX group, 0.9% saline group and GR blocking group (10^-2mol/L RU486). All agents were administrated through the femoral vein. CRH protein expression was measured by immunohistochemistry and laser confocal scanning microscopy (LCSM); CRH mRNA level was explored by in situ hybridization. Results: 10^-6 mol/L DEX made CRH mRNA transcripted after 20 min and its protein expressed in PVN after 30 min, while normal level of DEX and 0.9% saline could not. If GR was blocked in advance, the effect of high dose of DEX disappeared. Conclusion : High dose of GC can have CRH increased in PVN, which differs to the effect of traditional GC. And mGRH may play an important role in the effect of high dose of GC but not classic iGR. 展开更多
关键词 GLUCOCORTICOID high dose corticotropin releasing hormone
在线阅读 下载PDF
A Small Solitary Pulmonary Nodule Discovered by ^(18)F-fluorodeoxyglucose Positron Emission Tomography and CT: Rare Infection Instead of Rare Tumor
5
作者 Da-ming Zhang Hua-dan Xue +3 位作者 Lian Duan Ji Li Nai-shi Li Zheng-yu Jin 《Chinese Medical Sciences Journal》 CAS CSCD 2012年第4期249-252,共4页
THE causes of Cushing's syndrome are mainly di- vided into adrenocorticotropic hormone (ACTH) dependent and independent. ACTH dependent hypercortisolism represents excess ACTH se-creting by the pituitary or tumor o... THE causes of Cushing's syndrome are mainly di- vided into adrenocorticotropic hormone (ACTH) dependent and independent. ACTH dependent hypercortisolism represents excess ACTH se-creting by the pituitary or tumor outside the pituitary; and the latter one is also called as ectopic ACTH syndrome. Thorax is the most common location of causative lesions for ectopic ACTH syndrome, and the size of lesion is too small to be detected in some cases.1' 2 Cryptococcal pneumonia usually occurs in immunocompromised patients and excess cortisol production can theoretically produce a state of immunodeficiency. Development of cryptococcal pneumonia concomitant with Cushing syndrome (CS) was rare. Here, we report a case of pulmonary nodule in a patient with CS differentiated with ectopic ACTH-producing tumor. Crypto- coccal pneumonia was diagnosed followinglung resection. 展开更多
关键词 Cushing syndrome pulmonary cryptococcosis ectopic adrenocorticotropichormone-producing tumor
在线阅读 下载PDF
Effect of Xylazine-Ketamine Anesthesia on Blood ACTH, Cortisol, Adrenaline, Insulin and Glucose in Ovariohysterectomized Cats
6
作者 Nadya Zlatozareva Zlateva-Panayotova Bogdan Yanev Aminkov 《Journal of Life Sciences》 2015年第5期248-253,共6页
A study has been carried out with fourteen healthy mature cats in order to determine the effect of a xylazine-ketamine anesthetic protocol (group X/K) on blood concentrations of adrenaline, ACTH (adrenocorticotropi... A study has been carried out with fourteen healthy mature cats in order to determine the effect of a xylazine-ketamine anesthetic protocol (group X/K) on blood concentrations of adrenaline, ACTH (adrenocorticotropic hormone), cortisol, insulin and glucose in comparison with a control group (group K--no anesthesia and surgery). The animals were randomly allocated in two groups (n = 7). The premeditation in the experimental group was made with xylazine 2 mg/kg intramuscularly. Induction and maintenance of anesthesia were made with ketamine 10 mg/kg intramuscularly. Ovariohysterectomy was performed upon occurrence of deep anesthesia. Blood specimens were obtained at 0, 30, 60, 120 min and 24 h from the two groups. Pronounced decrease in blood ACTH, cortisol, and adrenaline in group X/K was determined by the 30 min. Significant hyperglycemia together with hyperinsulinemia in the X/K group was established at the 120 min from the beginning of the anesthesia. Anesthesia with xylazine and ketamine led to reduction of the blood levels of stress hormones immediately after the beginning of anesthesia and caused a remarkable hyperglycemia with hyperinsulinemia. 展开更多
关键词 ANESTHESIA CATS ADRENALINE CORTISOL ACTH insulin.
在线阅读 下载PDF
Inhibiting effects of low-molecular weight heparin and adrenocortical hormone on hemolysis of red cells in patients with paroxysmal nocturnal hemoglobinuria in vitro 被引量:1
7
作者 赵明峰 邵宗鸿 +7 位作者 刘鸿 曹铮 田鹏 付蓉 施均 何广胜 白洁 杨天楹 《Chinese Medical Journal》 SCIE CAS CSCD 2002年第11期1620-1623,145-146,共4页
OBJECTIVE: To study the effects of low-molecular weight heparin (LMWH) and adrenocortical hormone (dexamethasone) on the hemolysis of red cells of patients with paroxysmal nocturnal hemoglobinuria (PNH) in vitro. METH... OBJECTIVE: To study the effects of low-molecular weight heparin (LMWH) and adrenocortical hormone (dexamethasone) on the hemolysis of red cells of patients with paroxysmal nocturnal hemoglobinuria (PNH) in vitro. METHODS: Using Ham's test and micro-complement lysis sensitive test (mCLST), the changes in hemolysis of red cells from 6 typical PNH cases were examined after adding LMWH and dexamethasone in different concentrations into the test solution in vitro. The effects of LMWH and dexamethasone on the coagulation of the tested blood samples were also studied using the activated partial thromboplastin time (APTT) test. RESULTS: Both LMWH and dexamethasone inhibited the hemolysis of PNH red cells, and they also showed a synergistic effect. The inhibiting effects were dose-dependent. Moreover, a tolerable dose of LMWH induced a limited prolongation of APTT. Dexamethasone showed two possible mechanisms in the inhibition of PNH red cells hemolysis through Ham's test and mCLST, respectively: (1) inhibiting both antibodies binding to red cells and (2) the initiation of the activation of complement 3 (C3). LMWH could inhibit hemolysis as determined by both Ham's test and mCLST, which indicated that LMWH could block the activation of complement cascade. CONCLUSIONS: Both LMWH and dexamethasone could inhibit hemolysis in PNH, and they showed a synergistic effect. Their mechanisms of inhibiting hemolysis differed from each other. Furthermore, a tolerable dose of LMWH induced a limited prolongation of APTT. LMWH might be useful for controlling acute hemolysis in patients with PNH and reducing the dose of adrenocortical hormone. 展开更多
关键词 DEXAMETHASONE Dose-Response Relationship Drug Hemoglobinuria Paroxysmal HEMOLYSIS Heparin Low-Molecular-Weight Humans Partial Thromboplastin Time
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部